ReviewNature2018
Challenges and opportunities in controlling mosquito-borne infections.
Review in Nature, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
94 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Significance of vertical transmission of arboviruses in mosquito-borne disease epidemiology.Parasites & vectors · 2025Pooled it
- A Systematic Review of Mathematical Models of Dengue Transmission and Vector Control: 2010-2020.Viruses · 2023Pooled it
- The worldwide seroprevalence of DENV, CHIKV and ZIKV infection: A systematic review and meta-analysis.PLoS neglected tropical diseases · 2021Pooled it
- Projecting the future of dengue under climate change scenarios: Progress, uncertainties and research needs.PLoS neglected tropical diseases · 2020Pooled it
- Trial
- Infodemiology of West Nile Virus in Greece, 2024-2025, with Descriptive One Health Preparedness Evidence from Crete.Epidemiologia (Basel, Switzerland) · 2026Article
- Vector control strategies for preventing dengue transmission.The Cochrane database of systematic reviews · 2026Article
- Research Trends and Collaborative Patterns inInternational journal of environmental research and public health · 2026Article
- Next-Generation Vaccines Against Neglected Diseases: New Promises from Genetically Modified Live-Attenuated Parasites and RNA Vaccines.Microorganisms · 2026Review
- Clashing in Murky Waters: On Amphibian Mosquito Suppression.Ecology and evolution · 2026Article
- Beyond Chikungunya: Hidden risks of anti-mosquito chemicals.Eco-Environment & Health · 2026Article
- In silico DNA barcoding surpasses whole genome sequencing for species identification from vector surveillance pools.Scientific reports · 2026Article
- NativeJournal of tropical medicine · 2026Article
- Global epidemiological trends, distribution of NTDs and malaria, and disease burden projections for the next 15 years.Frontiers in public health · 2026Article
- Juvenile hormone induces phosphorylation of insulin/insulin-like growth factor signaling proteins in previtellogenic Aedes aegypti mosquitoes.Insect science · 2025Article
- Review
- Field validation of multiple species distribution models shows variation in performance for predicting Aedes albopictus distributions at the invasion edge.Parasites & vectors · 2025Article
- CRISPR/Cas9-germline editing ofScience advances · 2025Article
- Barriers to surveillance and control of re-emergence of the Chagas disease vector Triatoma infestans in Arequipa, Peru.PLoS neglected tropical diseases · 2025Article
- Innovative approaches to vector control: integrating genomic, biological, and chemical strategies.Annals of medicine and surgery (2012) · 2025Review
34 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Mosquito-borne diseases remain a major cause of morbidity and mortality across the tropical regions. Despite much progress in the control of malaria, malaria-associated morbidity remains high, whereas arboviruses-most notably dengue-are responsible for a rising burden of disease, even in middle-income countries that have almost completely eliminated malaria. Here I discuss how new interventions offer the promise of considerable future reductions in disease burden. However, I emphasize that intervention programmes need to be underpinned by rigorous trials and quantitative epidemiological analyses. Such analyses suggest that the long-term goal of elimination is more feasible for dengue than for malaria, even if malaria elimination would offer greater overall health benefit to the public.
Indexed as
Identifiers
30046071What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.